Graham, JeffreyJeffreyGrahamVogel, ArndtArndtVogelANN-LII CHENGBjarnason, Georg AGeorg ABjarnasonNeal, Joel WJoel WNeal2023-01-122023-01-122022-110305-7372https://scholars.lib.ntu.edu.tw/handle/123456789/627208We conducted a systematic literature review to identify evidence for cabozantinib activity in patients with solid tumors after prior checkpoint inhibitor (CPI) therapy.enCabozantinib; Checkpoint inhibitors; Hepatocellular carcinoma; Immunotherapy; Non-small cell lung cancer; Renal cell carcinoma; Tyrosine kinase inhibitor[SDGs]SDG3review10.1016/j.ctrv.2022.102453360377922-s2.0-85136486663WOS:000862869300001https://api.elsevier.com/content/abstract/scopus_id/85136486663